Gonzalo Barón‐Esquivias
A5071824004- Cardiac Arrhythmias and Treatments
- Atrial Fibrillation Management and Outcomes
- Cardiovascular Syncope and Autonomic Disorders
- Cardiac pacing and defibrillation studies
- Heart Rate Variability and Autonomic Control
- Cardiac electrophysiology and arrhythmias
- Health Systems, Economic Evaluations, Quality of Life
- Cardiac Valve Diseases and Treatments
- Blood Pressure and Hypertension Studies
- Cardiac Imaging and Diagnostics
- Cardiac Structural Anomalies and Repair
- Venous Thromboembolism Diagnosis and Management
- Antiplatelet Therapy and Cardiovascular Diseases
- Obstructive Sleep Apnea Research
- Neurology and Historical Studies
- Lipoproteins and Cardiovascular Health
- Pericarditis and Cardiac Tamponade
- Heart Failure Treatment and Management
- Takotsubo Cardiomyopathy and Associated Phenomena
- Cardiac, Anesthesia and Surgical Outcomes
- Coronary Interventions and Diagnostics
- Acute Myocardial Infarction Research
- Cardiac tumors and thrombi
- Cardiovascular Function and Risk Factors
- Botulinum Toxin and Related Neurological Disorders
Hospital Universitario Virgen del Rocío
2015-2024
Universidad de Sevilla
2015-2024
Centro de Investigación en Red en Enfermedades Cardiovasculares
2020-2023
Instituto de Biomedicina de Sevilla
2020-2023
Laboratoire Lorrain de Recherche en Informatique et ses Applications
2023
Instituto de Biotecnología de León
2022-2023
Centro de Investigación Biomédica en Red
2020-2023
IVI Sevilla Clinic
2021-2022
Junta de Andalucía
2020-2022
Sociedad Española de Cardiología
2005-2019
The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their publication.The is not responsible in event any contradiction, discrepancy and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical...
The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their publication.The is not responsible in event any contradiction, discrepancy and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical...
The ESC/EACTS Guidelines represent the views of ESC and EACTS were arrived at after careful consideration available evidence time they written.Health professionals are encouraged to take them fully into account when exercising their clinical judgement.The guidelines do not, however, override individual responsibility health make appropriate decisions in circumstances patients, consultation with that patient and, where necessary, patient's guardian or carer.It is also professional's verify...
The ESC Guidelines represent the views of and were arrived at after careful consideration available evidence time they written.Health professionals are encouraged to take them fully into account when exercising their clinical judgement.The guidelines do not, however, override individual responsibility health make appropriate decisions in circumstances patients, consultation with that patient and, where necessary, patient's guardian or carer.It is also professional's verify rules regulations...
The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their publication.The is not responsible in event any contradiction, discrepancy and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical...
The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their publication.The is not responsible in event any contradiction, discrepancy and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical...
The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their publication.The is not responsible in event any contradiction, discrepancy, and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical...
The ESC Guidelines represent the views of and were arrived at after careful consideration available evidence time they written.Health professionals are encouraged to take them fully into account when exercising their clinical judgement.The guidelines do not, however, override individual responsibility health make appropriate decisions in circumstances patients, consultation with that patient and, where necessary, patient's guardian or carer.It is also professional's verify rules regulations...
Guidelines for pre-operative cardiac risk assessment and perioperative management in non-cardiac surgery.
The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their publication.The is not responsible in event any contradiction, discrepancy, and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical...
Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force Management Valvular Heart Disease European Society Cardiology (ESC) and Association for Cardio-Thoracic Surgery (EACTS)
GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns patients newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non–vitamin K antagonist oral anticoagulant (NOAC), became available. This study sought to describe phase baseline data and compare these pre-NOAC era collected during 1. During 2,...
To describe the prevalence and associated factors of inappropriate doses direct oral anticoagulants (DOAC) in a national registry patients real clinical practice.Five hundred thirty outpatients with atrial fibrillation treated DOAC were included prospective, national, multicentre study. The appropriateness was defined according to recommendations European Heart Rhythm Association. Mean age 73 ± 9 years, 46% women. Two sixty-seven prescribed dabigatran, 190 rivaroxaban, apixaban. A total 172...
Pacing in vasovagal syncope remains controversial.The authors evaluated dual-chamber pacing with closed loop stimulation (DDD-CLS) patients cardioinhibitory syncope.This randomized, double-blind, controlled study included Canadian and Spanish age ≥40 years, high burden (≥5 episodes, ≥2 episodes the past year), a head-up tilt test (bradycardia <40 beats/min for 10 s or asystole >3 s). Patients were randomized to either DDD-CLS 12 months followed by sham DDI mode at 30 pulses/min (group A),...
ADA : adenosine deaminase AMI : acute myocardial infarction ANA : anti-nuclear antibody bFGF : basic fibroblast growth factor CK : creatine kinase CMR : cardiac magnetic resonance CMV : cytomegalovirus CP : Child–Pugh CRP : C-reactive protein CT : computed tomography EBV :
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and prevention sudden cardiac Death. The Task Force Management Patients Ventricular Arrhythmias Prevention Sudden Cardiac Death European Society Cardiology].
Previous studies suggested potential ethnic differences in the management and outcomes of atrial fibrillation (AF). We aim to analyse oral anticoagulant (OAC) prescription, discontinuation, risk adverse Asian patients with AF, using data from a global prospective cohort study.From GLORIA-AF Registry Phase II-III (November 2011-December 2014 for II, January 2014-December 2016 III), we analysed according their self-reported ethnicity (Asian vs. non-Asian), as well subgroups (Chinese, Japanese,...